Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE
Cohan, Stanley, Kappos, Ludwig, Giovannoni, Gavin, Wiendl, Heinz, Selmaj, Krzysztof, Havrdová, Eva Kubala, Rose, John, Greenberg, Steven, Phillips, Glenn, Ma, Wei, Wang, Ping, Lima, Gabriel, SabatellaLanguage:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458517735190
Date:
October, 2017
File:
PDF, 687 KB
english, 2017